A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00262
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

How Should We Determine the Value of CAR T-Cell Therapy?

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2019English

CAR T-Cell Design: A Long Road Ahead

The Lancet Haematology
Hematology
2018English

The Future: In Vivo CAR T Cell Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Next Frontiers in CAR T-Cell Therapy

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Resisting CAR T-Cell Therapy: A Case Study

Cancer Discovery
Oncology
2018English

CAR-T Cell Therapy in Melanoma: A Future Success Story?

Experimental Dermatology
BiochemistryDermatologyMolecular Biology
2018English

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

Teaming Up for CAR-T Cell Therapy

Haematologica
Hematology
2019English

Current Approaches to Increase CAR T Cell Potency in Solid Tumors: Targeting the Tumor Microenvironment

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy